| Literature DB >> 33814104 |
Sameh Nassar1, Ahmed Taher1, Rosario Spear1, Felicia Wang2, John E Madewell1, Bilal Mujtaba3.
Abstract
Multiple myeloma is a common hematologic malignancy of plasma cells. Differentiating multiple myeloma from the precursor stages of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma is very important because the treatment approach is different for each. The diagnosis is mainly clinical, while the role of imaging is confined to the staging process, assessing response to therapy, and monitoring for disease progression. In this article, we examine the role of different imaging modalities in patients with multiple myeloma. Published by Elsevier Inc.Entities:
Year: 2020 PMID: 33814104 DOI: 10.1053/j.sult.2020.08.019
Source DB: PubMed Journal: Semin Ultrasound CT MR ISSN: 0887-2171 Impact factor: 1.875